Regencell Bioscience Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGC research report →
Price Chart
About the company
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
- CEO
- Yat-Gai Au
- IPO
- 2021
- Employees
- 10
- HQ
- Hong Kong, HK
Get TickerSpark's AI analysis on RGC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.78B
- P/E
- -498.59
- PEG
- 5.15
- P/S
- 0.00
- P/B
- 2871.11
- EV/EBITDA
- -498.70
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -231.87%
- ROIC
- -444.21%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-392,743+47.3%
- Op Income
- $-3,769,985
- Net Income
- $-3,584,213+16.7%
- EPS
- $-0.01+17.2%
- OCF Growth
- +22.2%
- FCF Growth
- +18.5%
- 52W High
- $69.00
- 52W Low
- $4.51
- 50D MA
- $5.94
- 200D MA
- $18.94
- Beta
- 1.43
- RSI (14)
- 64
- Avg Volume
- 199.19K
No earnings-call transcripts are available for RGC yet.
- Free Float
- 3.5%
- Shares Outstanding
- 495.47M
- Float Shares
- 17.28M
of shares held by institutions
37 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for RGC, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Geode Capital Management, LLC | 422.01K | ▲ 6.44K |
| Alyeska Investment Group, L.P. | 416.26K | ▲ 416.26K |
| Legal & General Group PLC | 128.00K | ▲ 118.10K |
| Jane Street Group, LLC | 98.35K | ▲ 98.35K |
| Xtx Topco Ltd | 60.06K | ▲ 60.06K |
| Amundi | 47.16K | ▲ 38.56K |
| Ubs Group AG | 43.21K | ▲ 19.32K |
| Quadrature Capital Ltd | 41.75K | ▲ 41.75K |
| Susquehanna International Group, Llp | 23.13K | ▲ 23.13K |
| Squarepoint Ops LLC | 22.04K | ▼ 4.58K |
| Fox Run Management, L.L.C. | 20.69K | ▲ 20.69K |
| Cibc Asset Management Inc | 15.29K | ▲ 15.29K |
Held by 5 ETFs
Biggest fund positions in RGC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 26 | LO WILLIAM WING YAN DR | sell | 70,600 |
| May 27, 26 | HUI EVANA YEE WAH | sell | 19,000 |
| Mar 18, 26 | LO WILLIAM WING YAN DR | other | 592,230 |
| Mar 18, 26 | LO MARGARET HOOR HAN | other | 0 |
| Mar 18, 26 | LO MARGARET HOOR HAN | other | 592,230 |
| Mar 18, 26 | HUI EVANA YEE WAH | other | 592,230 |
| Mar 18, 26 | CHAN HO YAU | other | 740,278 |
| Mar 18, 26 | CHUNG JAMES WAI HONG | other | 11,844,258 |
| Mar 18, 26 | AU YAT-PUI | other | 0 |
| Mar 18, 26 | AU YAT-GAI | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RGC coverage
Recent articles, reports, and earnings notes.
No research on RGC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGC report →Regencell Bioscience (NASDAQ:RGC) Releases Earnings Results
defenseworld.net · Oct 8
RGC Resources, Inc. Declares Quarterly Dividend
globenewswire.com · Sep 28
RGC Resources: More Likely To Appeal More To Income-Focused Investors
seekingalpha.com · Aug 18
RGC Resources Q3 Earnings Call Highlights
marketbeat.com · Aug 7
RGC Resources, Inc. Reports Third Quarter Earnings
globenewswire.com · Aug 5
United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises
seekingalpha.com · Jul 6
RGC Resources, Inc. Declares Quarterly Dividend
globenewswire.com · Jun 29
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
globenewswire.com · Jun 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.